For more than 15 years, virologist Chris Buck has worked to…
Category: Drug Development
Home /
Pancreatic cancer is an aggressive, highly lethal malignancy, with some of…
What if some of the most stubborn diseases could be treated…
Diphtheria is a preventable bacterial disease that causes a thick membrane…
Staphylococcus aureus (staph), the microbe responsible for common skin infections and…
Drug discovery has long been a gamble—slow, costly, and plagued by…
Your skin isn’t just a passive shield—it’s a finely tuned sensor,…
As avian influenza, or bird flu, continues to circulate globally, researchers…
Picture your GPS system of choice — Google Maps, Apple Maps,…
In an innovative twist on recycling, scientists have coaxed bacteria into…
A new type of drug delivery device in development could someday…
HIV remains a global health crisis, infecting more than 1 million…
Gonorrhea is one of the most widespread sexually transmitted infections, with…
Like many neurodegenerative diseases, early diagnosis and treatment of Alzheimer’s disease…
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the…
Over the past five years, scientists have slowly gained a better…
In a historic move, the White House announced steep price reductions…
Exsilio Therapeutics, a Boston-based biotech startup, has secured $82 million in…
For individuals with life-threatening food allergies, everyday activities like dining out…
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
Webinars
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
Brewing Immunity: The Science and Controversy of Vaccine Beer
March 16, 2026
For more than 15 years, virologist Chris Buck has worked to develop a vaccine against BK polyomavirus, a pathogen that quietly infects most people but
Disabling the “Shield” That Enables Pancreatic Cancer
March 11, 2026
Pancreatic cancer is an aggressive, highly lethal malignancy, with some of the highest mortality rates of all major cancers. In fact, per the Pancreatic Cancer
Nanoparticles That Clean House: A New Strategy for Eliminating Disease-Causing Proteins
February 16, 2026
What if some of the most stubborn diseases could be treated not by blocking harmful proteins, but by removing them altogether? Early research investigating the
When Old Diseases Roar Back: Understanding Diphtheria’s Resurgence
December 8, 2025
Diphtheria is a preventable bacterial disease that causes a thick membrane to form in the back of the throat, making swallowing and breathing difficult. It
Stuck Like Superglue: How Staph Bacteria Grip Human Skin
October 6, 2025
Staphylococcus aureus (staph), the microbe responsible for common skin infections and severe methicillin-resistant Staphylococcus aureus (MRSA) outbreaks, doesn’t just land on human skin—it forms an
AI Model Cracks the Code for Drug Design
September 15, 2025
Drug discovery has long been a gamble—slow, costly, and plagued by high failure rates. Researchers spend years screening libraries of molecules, hoping to stumble upon
The Cool Code: How Your Skin Sends a Chill to the Brain
August 25, 2025
Your skin isn’t just a passive shield—it’s a finely tuned sensor, and scientists have now mapped the full circuit that lets you feel a gentle
Does Past Flu Exposure Protect Against the Bird Flu?
August 18, 2025
As avian influenza, or bird flu, continues to circulate globally, researchers are examining the possibility of cross-protection from past seasonal flu infections. While it’s known
The Role of AI in the Fight Against Cancer
August 13, 2025
Picture your GPS system of choice — Google Maps, Apple Maps, and the like. You plug in a location, follow the directions, and arrive at
Biochemical Breakthrough Turns Plastic Waste into Painkillers
July 28, 2025
In an innovative twist on recycling, scientists have coaxed bacteria into converting discarded plastic bottles into paracetamol, the active ingredient in widely used painkillers. Using
Squid-Inspired Microjet Device Could Enable More Direct Drug Delivery
February 3, 2025
A new type of drug delivery device in development could someday bypass the challenges and fears associated with certain types of injectable drugs. In collaboration
A Shot at Ending HIV: The Promise of Lenacapavir
January 27, 2025
HIV remains a global health crisis, infecting more than 1 million people annually. Although research has advanced to treat people who become infected, a vaccine
New Antibiotic Could Simplify Gonorrhea Treatment
November 20, 2024
Gonorrhea is one of the most widespread sexually transmitted infections, with as many as 82 million new infections occurring worldwide each year. While not all
Early Alzheimer’s Patients Benefit from Leqembi
November 13, 2024
Like many neurodegenerative diseases, early diagnosis and treatment of Alzheimer’s disease (AD) can greatly improve quality of life for individuals with the disease. Now, thanks
Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE), a
Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
September 23, 2024
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge of
Medicare Price Cuts Promise Relief to Seniors
September 9, 2024
In a historic move, the White House announced steep price reductions for ten prescription drugs under Medicare thanks to the Inflation Reduction Act (IRA). This
Can Repeat Dosing with RNA Medicines Be Curative?
August 26, 2024
Exsilio Therapeutics, a Boston-based biotech startup, has secured $82 million in funding and hopes to target genetic conditions with a new approach to gene therapy.
FDA Approves New Drug for Food Allergies
August 21, 2024
For individuals with life-threatening food allergies, everyday activities like dining out and traveling can be tremendously stressful, as even the smallest traces of the allergen
Boosting Oncology Research with Artificial Intelligence
May 6, 2024
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing the precision of cancer diagnostics and accelerating drug development processes. AI and machine learning
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…